Department of Biomedical and Clinical Sciences, Linköping University, 58183, Linköping, Sweden.
Department of Animal Health and Antimicrobial Strategies, National Veterinary Institute (SVA), 75189, Uppsala, Sweden.
Acta Vet Scand. 2020 Apr 25;62(1):18. doi: 10.1186/s13028-020-00516-4.
Sweden has a long tradition of monitoring occurrence of antibiotic resistant bacteria in both animals and humans, but there currently is no organised and harmonized monitoring on carriage of Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBL), plasmid-mediated AmpC beta-lactamase (pAmpC), or methicillin-resistant coagulase positive staphylococci e.g. methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus pseudintermedius (MRSP) in dogs. The aim of the current study was therefore to determine the prevalence of ESBL/pAmpC producing Enterobacteriaceae and methicillin-resistant coagulase positive staphylococci in healthy dogs in Sweden, and to phenotypically and genotypically characterize any identified isolates. It was shown that 0.9% (95% confident interval 0.3-2.7%) of the dogs (n = 325) carried multi-resistant ESBL-producing Escherichia coli, but that no methicillin-resistant coagulase positive staphylococci could be detected. In conclusion, the occurrence of multi-drug resistant bacteria remains rare among healthy dogs in Sweden. In addition, the ESBL-producing E. coli identified showed genetic characteristics related to those reported from humans.
瑞典在监测动物和人类中抗生素耐药菌的发生方面有着悠久的传统,但目前对于产超广谱β-内酰胺酶(ESBL)、质粒介导的头孢菌素酶(pAmpC)或耐甲氧西林凝固酶阳性葡萄球菌(如耐甲氧西林金黄色葡萄球菌(MRSA)和耐甲氧西林中间葡萄球菌(MRSP))的肠杆菌科的携带情况,尚未进行有组织和协调的监测。因此,本研究旨在确定健康犬中 ESBL/pAmpC 产肠杆菌科和耐甲氧西林凝固酶阳性葡萄球菌的流行率,并对鉴定出的分离株进行表型和基因型特征分析。结果表明,0.9%(95%置信区间 0.3-2.7%)的犬(n=325)携带多耐药 ESBL 产大肠埃希菌,但未检测到耐甲氧西林凝固酶阳性葡萄球菌。总之,在瑞典健康犬中,多药耐药菌的发生仍然很少见。此外,鉴定出的产 ESBL 的大肠杆菌表现出与从人类报告的相关的遗传特征。